Total investments received (USD): 86m
Round value (USD): 30m
Company: Storm Therapeutics
Industry:
Biotech
Health services









Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Italy
Portugal